TBC1D1 and glioma: Immunohistochemical analysis validated higher TBC1D1 expression levels in tumor tissues, and a substantial increase in TBC1D1 expression was observed in the glioma cell line, 1321N1 compared to the normal cell line HA1800 (Figures 2C–G).